AT346487B - Verfahren zur herstellung eines neuen 3,7- disubstituierten cephalosporins - Google Patents

Verfahren zur herstellung eines neuen 3,7- disubstituierten cephalosporins

Info

Publication number
AT346487B
AT346487B AT725776A AT725776A AT346487B AT 346487 B AT346487 B AT 346487B AT 725776 A AT725776 A AT 725776A AT 725776 A AT725776 A AT 725776A AT 346487 B AT346487 B AT 346487B
Authority
AT
Austria
Prior art keywords
cephalosporine
disubstituted
producing
new
disubstituted cephalosporine
Prior art date
Application number
AT725776A
Other languages
English (en)
Other versions
ATA725776A (de
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Priority to SE7713662A priority Critical patent/SE428012B/xx
Publication of ATA725776A publication Critical patent/ATA725776A/de
Application granted granted Critical
Publication of AT346487B publication Critical patent/AT346487B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT725776A 1975-10-01 1976-09-30 Verfahren zur herstellung eines neuen 3,7- disubstituierten cephalosporins AT346487B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE7713662A SE428012B (sv) 1976-09-30 1977-12-01 Bruk for murning av eldfasta stenar

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40063/75A GB1500010A (en) 1975-10-01 1975-10-01 3,7-disubstituted cephalosporins and their preparation

Publications (2)

Publication Number Publication Date
ATA725776A ATA725776A (de) 1978-03-15
AT346487B true AT346487B (de) 1978-11-10

Family

ID=10413000

Family Applications (1)

Application Number Title Priority Date Filing Date
AT725776A AT346487B (de) 1975-10-01 1976-09-30 Verfahren zur herstellung eines neuen 3,7- disubstituierten cephalosporins

Country Status (18)

Country Link
US (1) US4073903A (de)
JP (1) JPS5242896A (de)
AR (1) AR212506A1 (de)
AT (1) AT346487B (de)
AU (1) AU1681976A (de)
BE (1) BE846741A (de)
BR (1) BR7606049A (de)
DE (1) DE2643920A1 (de)
DK (1) DK437076A (de)
ES (1) ES451860A1 (de)
FR (1) FR2326195A1 (de)
GB (1) GB1500010A (de)
GR (1) GR61357B (de)
IL (1) IL50221A0 (de)
IN (1) IN145002B (de)
NL (1) NL7610817A (de)
SE (1) SE7610821L (de)
ZA (1) ZA764804B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59112990A (ja) * 1982-12-21 1984-06-29 Asahi Chem Ind Co Ltd 新規セフアロスポリン類

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1051746A (de) * 1961-12-22
US3719672A (en) * 1968-12-11 1973-03-06 Ciba Geigy Corp 4-substituted methylene-7-amino-8-oxo-5-thia-1-aza-bicyclo(4,2,0 oct-2-ene-2-carboxylic acids
IL36719A0 (en) * 1970-05-04 1971-06-23 Ciba Geigy Ag Derivatives of 7-aminocephalosporanic acid,their manufacture and pharmaceutical compositions containing them
DE2118635A1 (de) * 1971-04-17 1972-11-02 Farbwerke Hoechst AG, vormals Meister Lucius & Brüning, 6000 Frankfurt Acylaminocephalosporansäuren und Verfahren zu ihrer Herstellung
US4008231A (en) * 1975-09-15 1977-02-15 Eli Lilly And Company Preparation of 3-methoxymethylcephalosporins
US4008230A (en) * 1975-10-29 1977-02-15 Eli Lilly And Company Process for preparing 3-hydroxy cephalosporins
US4031082A (en) * 1976-01-19 1977-06-21 Eli Lilly And Company Process for preparing 3-acycloxymethyl-2-cephem compounds

Also Published As

Publication number Publication date
DK437076A (da) 1977-04-02
FR2326195A1 (fr) 1977-04-29
AR212506A1 (es) 1978-07-31
ATA725776A (de) 1978-03-15
DE2643920A1 (de) 1977-04-07
JPS5242896A (en) 1977-04-04
IL50221A0 (en) 1976-10-31
ES451860A1 (es) 1978-05-01
GB1500010A (en) 1978-02-08
BE846741A (fr) 1977-01-17
BR7606049A (pt) 1977-08-23
IN145002B (de) 1978-08-12
AU1681976A (en) 1978-02-16
ZA764804B (en) 1977-09-28
US4073903A (en) 1978-02-14
SE7610821L (sv) 1977-04-02
GR61357B (en) 1978-10-26
NL7610817A (nl) 1977-04-05

Similar Documents

Publication Publication Date Title
DD132786A5 (de) Verfahren zur herstellung eines neuen oximaethers
AT355238B (de) Verfahren zur herstellung eines neuen hentriakontapeptids
AT349759B (de) Verfahren zur herstellung eines neuen wasser- loeslichen polymerisats
AT342768B (de) Verfahren zur herstellung eines neuen antibiotikums
AT348142B (de) Verfahren zur herstellung von neuen 8,8- disubstituierten 6-methylergolinen
AT348141B (de) Verfahren zur herstellung eines neuen 6-methyl- 8- (substituierten) methylergolins
AT342023B (de) Verfahren zur herstellung von neuen 2,4-disulfonamidoanilinverbindungen
AT351185B (de) Verfahren zur herstellung eines neuen 11- desoxy-omega-pentanorprostaglandins
ATA136678A (de) Verfahren zur herstellung eines neuen morphanderivates
AT346487B (de) Verfahren zur herstellung eines neuen 3,7- disubstituierten cephalosporins
AT348163B (de) Verfahren zur herstellung eines neuen prostaglandinderivates
AT348127B (de) Verfahren zur herstellung eines neuen 3,7- disubstituierten cephalosporins
AT358725B (de) Verfahren zur herstellung eines neuen antibiotikums
AT340588B (de) Verfahren zur herstellung eines neuen antibiotikumderivates
AT346480B (de) Verfahren zur herstellung eines neuen antibiotisch wirksamen gemisches
AT342767B (de) Verfahren zur herstellung eines neuen antibiotikums
ATA348977A (de) Verfahren zur herstellung von neuen 3,7- disubstituierten cephalosporinen
AT367417B (de) Verfahren zur herstellung eines neuen 3,4dihydroxyzimtaldehydderivates
ATA472979A (de) Verfahren zur herstellung eines neuen praevitamins
AT344887B (de) Verfahren zur herstellung eines neuen antibiotikums
AT349139B (de) Verfahren zur herstellung eines neuen antibiotikums
AT348675B (de) Verfahren zur herstellung von neuen cephalosporinderivaten
ATA287777A (de) Verfahren zur herstellung eines neuen antibiotikums
AT352872B (de) Verfahren zur herstellung eines neuen anti- bioticums
DD131823A3 (de) Verfahren zur herstellung eines neuen antibiotikums

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee